Quest Diagnostics Reports Second Quarter 2026 Financial Results; Raises Revenue and EPS Guidance

Quest Diagnostics reported a 10.2% increase in net revenues to $3.043 billion for the second quarter of 2026, driven primarily by organic growth. Adjusted diluted EPS rose by 19.1%. The company has raised its full-year guidance for both net revenues and EPS following strong financial performance and operational execution.